NeuronNeurosciencePeer-reviewed journal article
Alzheimer's disease-linked risk alleles elevate microglial cGAS-associated senescence and neurodegeneration in a tauopathy model
Gillian CarlingiD, Li FaniD, Nessa R. Foxe, Kendra Norman, Man Ying WongiD, Daphne Zhu, Carlo CoronaiD, Agnese RazzoliiD, Fangmin Yu, Allan YarahmadyiD, Pearly Ye, Hao CheniD, Yige HuangiD, Sadaf AminiD, Rebecca SeredaiD, Chloe Lopez-LeeiD, Emmanouil ZacharioudakisiD, Xiaoying CheniD, Jielin Xu, Feixiong ChengiD, Evripidis GavathiotisiD, Ana María CuervoiD, David M. HoltzmaniD, Sue‐Ann MokiD, Subhash C. SinhaiD, , Li GaniD
Abstract
The strongest risk factors for Alzheimers disease (AD) include the {chi}4 allele of apolipoprotein E (APOE), the R47H variant of triggering receptor expressed on myeloid cells 2 (TREM2), and female sex. Here, we combine APOE4 and TREM2R47H (R47H) in female P301S tauopathy mice to identify the pathways activated when AD risk is the strongest, thereby highlighting disease-causing mechanisms. We find that the R47H variant induces neurodegeneration in female APOE4 mice without impacting hippocampal tau load. The combination of APOE4 and R47H amplified tauopathy-induced cell-autonomous microglial cGAS-STING signaling and type-I interferon response, and interferon signaling converged across glial cell types in the hippocampus. APOE4-R47H microglia displayed cGAS- and BAX-dependent upregulation of senescence, showing association between neurotoxic signatures and implicating mitochondrial permeabilization in pathogenesis. By uncovering pathways enhanced by the strongest AD risk factors, our study points to cGAS-STING signaling and associated microglial senescence as potential drivers of AD risk.
- Citations
- 85
- FWCI
- 24.19
- Field percentile
- top 1%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- APOE4 exacerbates glucocorticoid stress hormone-induced tau pathology via mitochondrial dysfunction
Qing Yu, Fang Du, … Clarissa L. Waites·Cell Death and DiseasePeer-reviewed·Mar 27, 2026
- Neuronal APOE4 alone is sufficient to drive tau pathology, neurodegeneration, and neuroinflammation in an Alzheimer's disease mouse model
Jessica R. Blumenfeld, Yaqiao Li, … Yadong Huang·bioRxiv·Nov 25, 2025
- Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
Sivaprakasam R. Saroja, Kirill Gorbachev, … Ana C. Pereira·bioRxiv·Jul 7, 2021
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology
Kristine M. Tran, Nellie E. Kwang, … Kim N. Green·Molecular NeurodegenerationPeer-reviewed·Jan 22, 2025
- Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer's disease risk in humans
Yiyi Ma, Lei Yu, … Philip L. De Jager·Alzheimer s & DementiaPeer-reviewed·Dec 1, 2020
- AD-linked R47H-TREM2 mutation induces disease-enhancing proinflammatory microglial states in mice and humans
Faten A. Sayed, Lay Kodama, … Li Gan·bioRxiv·Jul 24, 2020